Related Experiment Video
Updated: Feb 13, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA
Published on: February 9, 2011
Community-acquired Pneumonia with Methicillin-resistant Staphylococcus Aureus in a Patient Admitted to the Intensive
John Pham1, Talal Asif1, Majdi S Hamarshi2
1Department of Internal Medicine, University of Missouri Kansas City (UMKC).
Abstract:
Methicillin-resistant Staphylococcus aureus (MRSA) was previously considered a purely nosocomial pathogen. However, community-acquired MRSA has recently emerged as an important cause of severe necrotizing community-acquired pneumonia (CA-MRSA) in previously healthy individuals. This new pathogen exhibits antibiotic resistance and is linked to extended hospital stay and higher mortality. CA-MRSA has presented new therapeutic challenges due to high vancomycin treatment failure and lack of specificity of clinical findings. There is emerging evidence that treatment with linezolid leads to better patient outcomes in patients with CA-MRSA. Through this case, we aim to raise awareness about early institution of therapy for CA-MRSA whenever it is suspected, to improve patient outcomes.
Insights
Community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) causes severe pneumonia in healthy individuals. Early linezolid therapy may improve outcomes for this challenging infection.
Area of Science:
- Infectious Diseases
- Pulmonary Medicine
- Microbiology
Background:
- Methicillin-resistant Staphylococcus aureus (MRSA) traditionally a hospital-acquired pathogen.
- Emergence of community-acquired MRSA (CA-MRSA) as a significant cause of severe pneumonia.
- CA-MRSA infections present unique challenges including antibiotic resistance and high mortality.
Observation:
- CA-MRSA pneumonia observed in previously healthy individuals.
- High vancomycin treatment failure rates reported.
- Clinical findings for CA-MRSA pneumonia lack specificity.
Findings:
- CA-MRSA exhibits significant antibiotic resistance.
- Infections linked to prolonged hospital stays and increased mortality.
- Emerging evidence suggests linezolid improves patient outcomes.
Implications:
- Need for increased awareness of CA-MRSA as a community pathogen.
- Importance of early suspicion and diagnosis of CA-MRSA pneumonia.
- Consideration of linezolid for improved therapeutic outcomes in CA-MRSA infections.
More Related Videos
Related Concept Videos
Patient-centered Care
What are Populations and Communities?
Measurement: Derived Units
Measurement: Standard Units
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology

